Observes improved outcomes in high-risk recipients undergoing cardiac re-transplantation, suggesting a novel approach.
Cardiac re-transplantation is very rare and carries considerably increased peri-operative risk. Donation after circulatory death (DCD), combined with ex-situ normothermic perfusion, has expanded the donor pool with favourable early outcomes, but there is a paucity of experience of its use in cardiac re-transplantation. We report the first UK case of orthotopic heart re-transplantation using a controlled DCD donor preserved on ex-situ normothermic perfusion 140 days after index transplantation complicated by severe irrecoverable primary graft failure – defined as immediate presentation early graft dysfunction involving both ventricles as per recent International Society for Heart and Lung Transplantation guidelines.
No takes yet. Share an insight, caveat, or question.
Cannon et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: